{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:10:02Z","timestamp":1759065002246,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.bbr.2009.03.037","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T04:56:30Z","timestamp":1239080190000},"page":"232-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice"],"prefix":"10.1016","volume":"202","author":[{"given":"Anti","family":"Kalda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Herm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ago","family":"Rinken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Zharkovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2009.03.037_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410330515","article-title":"Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys","volume":"33","author":"Akai","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.03.037_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.03.037_bib3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1212\/WNL.42.6.1241","article-title":"Partial dopamine agonist therapy of levodopa-induced dyskinesias","volume":"42","author":"Baronti","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.03.037_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(98)00307-4","article-title":"Pramipexole\u2014a new dopamine agonist for the treatment of Parkinson's disease","volume":"163","author":"Bennett","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbr.2009.03.037_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"B\u00e9zard","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bbr.2009.03.037_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.20612","article-title":"Nondopaminergic mechanisms in levodopa-induced dyskinesia","volume":"20","author":"Brotchie","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.03.037_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01249001","article-title":"Dopamine receptor agonists: intrinsic activity vs. state of receptor","volume":"57","author":"Carlsson","year":"1983","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2009.03.037_bib8","first-page":"2694","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2009.03.037_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01252236","article-title":"Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations","volume":"62","author":"Clark","year":"1985","journal-title":"J Neural Transm"},{"issue":"Suppl.","key":"10.1016\/j.bbr.2009.03.037_bib10","first-page":"iv37","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson's disease?","volume":"252","author":"Fahn","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2009.03.037_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2009.03.037_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00450549","article-title":"Terguride in parkinsonism. A multicenter trial","volume":"237","author":"Filipov\u00e1","year":"1988","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"10.1016\/j.bbr.2009.03.037_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0169-328X(92)90173-9","article-title":"Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum","volume":"14","author":"Fink","year":"1993","journal-title":"Brain Res Mol Brain Res"},{"year":"1997","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","key":"10.1016\/j.bbr.2009.03.037_bib14"},{"key":"10.1016\/j.bbr.2009.03.037_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1523\/JNEUROSCI.22-03-01054.2002","article-title":"Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors","volume":"22","author":"Fredduzzi","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.03.037_bib16","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/01.WNL.0000095206.44418.5C","article-title":"Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease","volume":"61","author":"Fuxe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.03.037_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp Neurol"},{"issue":"Suppl. 11","key":"10.1016\/j.bbr.2009.03.037_bib18","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.bbr.2009.03.037_bib19","first-page":"S1","article-title":"Pharmacology of dopamine agonists in the treatment of Parkinson's disease","volume":"58","author":"Jenner","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.03.037_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0169-328X(95)00084-6","article-title":"L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP","volume":"32","author":"Jolkkonen","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bbr.2009.03.037_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pnpbp.2006.09.007","article-title":"Dopamine D2 receptor partial agonist display differential or contrasting characteristics in membrane and cell-based assay of dopamine D2 receptor signaling","volume":"31","author":"Jordan","year":"2007","journal-title":"Prog Neuro-Psychoph"},{"key":"10.1016\/j.bbr.2009.03.037_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact","volume":"28","author":"Mailman","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bbr.2009.03.037_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0026-895X(25)10474-4","article-title":"Relationship between receptor occupancy and response at striatal dopamine autoreceptors","volume":"31","author":"Meller","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2009.03.037_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mds.870090512","article-title":"Motor effects of the partial dopamine agonist (\u2013)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's disease","volume":"9","author":"Metman","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.03.037_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-6147(02)00027-5","article-title":"Principles: extending the utility of [35S]GTP gamma S binding assays","volume":"24","author":"Milligan","year":"2003","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl. 10","key":"10.1016\/j.bbr.2009.03.037_bib26","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2009.03.037_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/mds.870080408","article-title":"Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo","volume":"8","author":"Pacchetti","year":"1993","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.03.037_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-2952(98)00287-1","article-title":"Pharmacological characterization of dopamine-stimulated [35S]GTPgammaS binding in rat striatal membranes","volume":"57","author":"Rinken","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2009.03.037_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","article-title":"Novel pharmacological targets for the treatment of Parkinson's disease","volume":"5","author":"Schapira","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bbr.2009.03.037_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cne.903170202","article-title":"Ontogeny of gene expression of adenosine A2 receptor in the striatum: early localization in the patch compartment","volume":"317","author":"Schiffmann","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.03.037_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(00)00776-X","article-title":"Modulation of [(35)S]GTPgammaS binding to Chinese hamster ovary cell membranes by D(2(short)) dopamine receptors","volume":"280","author":"Terasmaa","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.03.037_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.bbr.2009.03.037_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(94)37048-6","article-title":"Measurement of receptor-stimulated guanosine 5\u2032-O-(gamma-thio)triphosphate binding by G proteins","volume":"237","author":"Wieland","year":"1994","journal-title":"Method Enzymol"},{"key":"10.1016\/j.bbr.2009.03.037_bib34","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1523\/JNEUROSCI.3554-06.2006","article-title":"Forebrain adenosine A2A receptors contribute to L-3 4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice","volume":"26","author":"Xiao","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.03.037_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2005.09.036","article-title":"Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice","volume":"393","author":"Yu","year":"2006","journal-title":"Neurosci Lett"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809002010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809002010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:57:36Z","timestamp":1759064256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432809002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0166432809002010"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2009.03.037","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2009.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}